Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | — | OT |
stroke-like symptoms; indication : Pneumococcal Disease; confusion; fatigue; severe lethargy; This spontaneous report was received from a medical assistant via company representative and refers to a female patient in her 50's. The patient's concurrent conditions, medical history and concomitant therapies were not provided. On an unknown date, she was vaccinated with Pneumococcal 21-valent Conjugate Vaccine Solution for injection (CAPVAXIVE) 168 mcg/ml injection, 0.5 ml intramuscularly (lot # and expiration date were not provided) for "Pneumococcal Disease" (Product use in unapproved indication). On an unknown date, the patient experienced severe lethargy, fatigue, confusion, and stroke-like symptoms. She went to the emergency department. The outcome of the events was not provided. Causality assessment was not reported. Upon internal review, the event of stroke-like symptoms was considered to be medically significant. Lot # is being requested and will be submitted if received.